Search Results 111-120 of 16441 for Cefprozil

  1. An Extension Study of Oral Ozanimod for Moderately-to-Severely Active Crohn's Disease - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  2. https://www.mayoclinic.org/chinese_patient_consumer_video.xml

  3. A Study of Paclitaxel with or without Cixutumumab as Second-Line Therapy for Treating Patients with Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer - Mayo Clinic

    Cixutumumab may kill cancer cells by blocking the action of a protein needed for cancer cell growth. Giving paclitaxel with or without cixutumumab may kill more ...

  4. I-124 evuzamitide PET/CT Imaging for the Diagnosis of Cardiac Amyloidosis - Mayo Clinic

    Inclusion Criteria: Understands the study procedures and can give signed informed consent (as specified in Section 10.1.3), which includes compliance with ...

  5. Cabozantinib-S-Malate in Treating Patients With Refractory Thyroid Cancer - Mayo Clinic

    About this study. This phase II trial studies how well cabozantinib-s-malate works in treating patients with thyroid cancer that does not respond to ...

  6. https://www.mayoclinic.org/chinese_patient_consumer_recipe.xml

  7. https://www.mayoclinic.org/~/media/FD382661FD544C6CB4A38FC785855FAB

  8. https://www.mayoclinic.org/spanish_patient_consumer_recipe.xml

  9. Levonorgestrel (intradermal route) - Side effects & uses - Mayo Clinic

    Cefprozil; Ceftazidime; Ceftibuten; Cefuroxime; Cenobamate; Ceritinib; Chlortetracycline; Clobazam; Clomipramine; Cloxacillin; Colesevelam; Cyclacillin ...

  10. A Study of an Implantable System for Remodulin Post Approval - Mayo Clinic

    Inclusion Criteria: Subject or legally authorized representative provides written authorization and/or consent per institution and geographical requirements ...